Go Pro
→ Bank of America: 'Digital Dollar Inevitable' (From Decentralized Masters) (Ad)tc pixel Free IRIX Stock Alerts

IRIDEX (IRIX) Financials

IRIDEX logo
$0.67 +0.02 (+2.81%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.66 -0.01 (-2.09%)
As of 09/18/2026 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IRIDEX

Annual Income Statements for IRIDEX

This table shows IRIDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders		 0.47 -12 -13 -13 -8.81 -5.23 -7.55 -9.57 -8.91 -4.44 -4.44
Consolidated Net Income / (Loss)		 0.47 -12 -13 -13 -8.81 -5.23 -7.55 -9.57 -8.91 -4.44 -4.44
Net Income / (Loss) Continuing Operations		 0.47 -12 -13 -13 -8.81 -5.23 -7.55 -9.57 -8.91 -4.44 -4.44
Total Pre-Tax Income 		0.29 -2.66 -13 -13 -8.77 -5.19 -7.48 -9.48 -8.84 -4.38 -4.38
Total Operating Income		 0.29 -2.57 -13 -13 -8.97 -7.53 -7.54 -10 -8.30 -2.57 -2.57
Total Gross Profit		 20 21 16 17 18 23 25 22 20 19 19
Total Revenue		 42 46 42 43 43 54 57 52 49 53 53
Operating Revenue		 42 46 42 43 43 54 57 52 49 53 53
Total Cost of Revenue		 22 25 26 25 26 31 32 30 29 33 33
Operating Cost of Revenue		 22 25 26 25 26 31 32 30 29 33 33
Total Operating Expenses		 20 23 28 30 27 30 33 32 28 22 22
Selling, General & Admin Expense		 5.55 7.64 8.78 9.55 8.38 8.86 7.56 8.75 9.78 7.73 7.73
Marketing Expense		 8.90 10 15 17 15 15 18 16 13 10 10
Research & Development Expense		 5.21 5.37 5.21 4.01 3.68 6.87 7.18 6.83 5.45 3.67 3.67
Total Other Income / (Expense), net		 0.00 -0.09 -0.11 0.09 0.21 2.35 0.06 0.53 -0.54 -1.81 -1.81
Other Income / (Expense), net		 0.00 -0.09 -0.11 0.09 0.21 2.35 0.06 0.53 -0.54 -1.81 -1.81
Income Tax Expense		 -0.18 9.06 -0.13 0.04 0.05 0.04 0.07 0.09 0.07 0.06 0.06
Basic Earnings per Share		 $0.05 ($1.15) ($1.11) ($1.05) ($0.64) ($0.34) ($0.47) ($0.59) ($0.54) ($0.26) ($0.26)
Weighted Average Basic Shares Outstanding		 9.96M 10.17M 11.56M 12.20M 13.71M 15.42M 15.94M 16.13M 16.44M 16.93M 16.93M
Diluted Earnings per Share		 $0.05 ($1.15) ($1.11) ($1.05) ($0.64) ($0.34) ($0.47) ($0.59) ($0.54) ($0.26) ($0.26)
Weighted Average Diluted Shares Outstanding		 10.13M 10.17M 11.56M 12.20M 13.71M 15.42M 15.94M 16.13M 16.44M 16.93M 16.93M
Weighted Average Basic & Diluted Shares Outstanding		 9.50M 11.52M 11.63M 13.63M 13.79M 15.88M 16.01M 16.25M 16.79M 17.31M 17.31M

Quarterly Income Statements for IRIDEX

This table shows IRIDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Total Costs & Expenses		 - - - - - - 5.62 - 5.49 - 5.33
Net Income / (Loss) Attributable to Common Shareholders		 -2.96 -3.46 -2.68 -1.93 -0.83 -1.69 -0.99 -1.57 -0.18 -0.52 -1.27
Consolidated Net Income / (Loss)		 -2.96 -3.46 -2.68 -1.93 -0.83 -1.69 -0.99 -1.57 -0.18 -0.52 -1.27
Net Income / (Loss) Continuing Operations		 -2.96 -3.46 -2.68 -1.93 -0.83 -1.69 -0.99 -1.57 -0.18 -0.52 -1.27
Total Pre-Tax Income 		-2.90 -3.43 -2.66 -1.92 -0.84 -1.67 -0.97 -1.57 -0.16 -0.47 -1.20
Total Operating Income		 -3.08 -3.29 -2.64 -1.87 -0.50 -0.21 -0.94 -1.41 -0.02 -0.32 -1.03
Total Gross Profit		 4.89 4.46 5.14 4.32 5.59 5.06 4.68 4.01 5.48 4.74 4.30
Total Revenue		 12 12 13 12 13 12 14 12 15 12 13
Operating Revenue		 12 12 13 12 13 12 14 12 15 12 13
Total Cost of Revenue		 7.57 7.30 7.50 7.26 7.11 6.84 8.89 8.47 9.25 7.06 8.27
Operating Cost of Revenue		 7.57 7.30 7.50 7.26 7.11 6.84 8.89 8.47 9.25 7.06 8.27
Total Operating Expenses		 7.97 7.75 7.77 6.19 6.09 5.26 5.62 5.42 5.49 5.07 5.33
Selling, General & Admin Expense		 2.41 2.47 2.79 2.25 2.28 1.93 2.22 1.80 1.79 1.62 1.84
Marketing Expense		 3.87 3.75 3.49 2.65 2.70 2.45 2.54 2.66 2.75 2.54 2.55
Research & Development Expense		 1.69 1.54 1.50 1.30 1.11 0.88 0.87 0.97 0.95 0.91 0.94
Total Other Income / (Expense), net		 0.18 -0.13 -0.02 -0.05 -0.34 -1.47 -0.03 -0.16 -0.15 -0.14 -0.17
Other Income / (Expense), net		 0.18 -0.13 -0.02 -0.05 -0.34 -1.47 -0.03 -0.16 -0.15 -0.14 -0.17
Income Tax Expense		 0.06 0.04 0.02 0.02 -0.01 0.01 0.02 0.00 0.02 0.06 0.07
Basic Earnings per Share		 ($0.18) ($0.21) ($0.16) ($0.12) ($0.05) ($0.10) ($0.06) ($0.09) ($0.01) ($0.03) ($0.07)
Weighted Average Basic Shares Outstanding		 16.13M 16.25M 16.29M 16.58M 16.44M 16.73M 16.79M 17.01M 16.93M 17.31M 17.42M
Diluted Earnings per Share		 ($0.18) ($0.21) ($0.16) ($0.12) ($0.05) ($0.10) ($0.06) ($0.09) ($0.01) ($0.03) ($0.07)
Weighted Average Diluted Shares Outstanding		 16.13M 16.25M 16.29M 16.58M 16.44M 16.73M 16.79M 17.01M 16.93M 17.31M 17.42M
Weighted Average Basic & Diluted Shares Outstanding		 16.25M 16.25M 16.51M 16.64M 16.79M 16.79M 16.99M 17.19M 17.31M 17.41M 17.56M

Annual Cash Flow Statements for IRIDEX

This table details how cash moves in and out of IRIDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026 1/3/2026
Net Change in Cash & Equivalents		 -3.31 14 -2.04 -0.51 -8.58 12 -9.93 -6.89 -4.65 3.64 3.64
Net Cash From Operating Activities		 -0.59 -0.14 -3.57 -10 -7.91 8.22 -9.52 -6.75 -7.29 -2.12 -2.12
Net Cash From Continuing Operating Activities		 -0.59 -0.14 -3.57 -10 -7.91 8.22 -9.52 -6.75 -7.29 -2.12 -2.12
Net Income / (Loss) Continuing Operations		 0.47 -12 -13 -13 -8.81 -5.23 -7.55 -9.57 -8.91 -4.44 -4.44
Consolidated Net Income / (Loss)		 0.47 -12 -13 -13 -8.81 -5.23 -7.55 -9.57 -8.91 -4.44 -4.44
Depreciation Expense		 0.52 0.65 0.86 0.81 0.69 0.80 0.49 1.10 0.58 0.52 0.52
Amortization Expense		 - - - - - 0.91 0.90 0.93 1.17 1.25 1.25
Non-Cash Adjustments To Reconcile Net Income		 0.96 2.06 1.78 1.81 1.73 -0.20 1.20 1.86 1.62 2.44 2.44
Changes in Operating Assets and Liabilities, net		 -2.55 8.86 6.66 0.17 -1.52 12 -4.55 -1.07 -1.75 -1.89 -1.89
Net Cash From Investing Activities		 -1.30 -1.47 -0.78 -0.83 -0.51 -5.56 -0.29 -0.11 -0.01 -0.14 -0.14
Net Cash From Continuing Investing Activities		 -1.30 -1.47 -0.78 -0.83 -0.51 -5.56 -0.29 -0.11 -0.01 -0.14 -0.14
Purchase of Property, Plant & Equipment		 -0.88 -1.06 -0.58 -0.44 -0.13 -0.21 -0.29 -0.11 -0.01 -0.14 -0.14
Net Cash From Financing Activities		 -1.42 15 2.31 10 -0.16 9.47 -0.07 -0.01 2.61 5.96 5.96
Net Cash From Continuing Financing Activities		 -1.42 15 2.31 10 -0.16 9.47 -0.07 -0.01 2.61 5.96 5.96
Repayment of Debt		 - - - - - - - 0.00 -0.71 -3.96 -3.96
Issuance of Debt		 - - - - 0.00 0.00 - 0.00 3.37 4.00 4.00
Issuance of Preferred Equity		 - - - - - - - - 0.00 6.00 6.00
Other Financing Activities, net		 0.42 0.61 0.04 -0.10 -0.16 -0.41 -0.07 -0.01 -0.05 -0.08 -0.08
Effect of Exchange Rate Changes		 - - - - - 0.10 -0.05 -0.03 0.05 -0.07 -0.07
Cash Income Taxes Paid		 0.03 0.02 0.01 0.01 0.01 0.02 0.07 0.05 0.02 -0.02 -0.02

Quarterly Cash Flow Statements for IRIDEX

This table details how cash moves in and out of IRIDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Net Change in Cash & Equivalents		 -0.95 -1.62 -1.31 -0.25 -1.47 4.86 -0.47 -1.21 0.46 -1.43 -0.32
Net Cash From Operating Activities		 -0.98 -1.65 -1.33 -3.07 -1.24 -1.15 -0.40 -1.16 0.59 -1.34 0.17
Net Cash From Continuing Operating Activities		 -0.98 -1.65 -1.33 -3.07 -1.24 -1.15 -0.40 -1.16 0.59 -1.34 -0.23
Net Income / (Loss) Continuing Operations		 -2.96 -3.46 -2.68 -1.93 -0.83 -1.69 -0.99 -1.57 -0.18 -0.52 -1.27
Consolidated Net Income / (Loss)		 -2.96 -3.46 -2.68 -1.93 -0.83 -1.69 -0.99 -1.57 -0.18 -0.52 -1.27
Depreciation Expense		 0.62 0.17 0.14 0.14 0.14 0.14 0.13 0.11 0.15 0.10 0.09
Amortization Expense		 0.16 0.23 0.23 0.27 0.44 0.38 0.28 0.29 0.30 0.30 0.31
Non-Cash Adjustments To Reconcile Net Income		 0.63 0.48 0.73 0.07 0.35 1.60 0.03 0.69 0.12 0.40 -0.33
Changes in Operating Assets and Liabilities, net		 0.57 0.94 0.26 -1.62 -1.32 -1.58 0.16 -0.67 0.20 -1.61 0.98
Net Cash From Investing Activities		 0.03 -0.00 - -0.00 -0.01 -0.01 -0.01 -0.01 -0.11 -0.10 -0.05
Net Cash From Continuing Investing Activities		 0.03 -0.00 - -0.00 -0.01 -0.01 -0.01 -0.01 -0.11 -0.10 -0.05
Purchase of Property, Plant & Equipment		 0.03 -0.00 - -0.00 -0.01 -0.01 -0.01 -0.01 -0.11 -0.10 -0.05
Net Cash From Financing Activities		 0.05 0.00 - 2.82 -0.22 6.04 -0.01 -0.03 -0.03 -0.00 -0.04
Net Cash From Continuing Financing Activities		 0.05 0.00 - 2.82 -0.22 6.04 -0.01 -0.03 -0.03 -0.00 -0.04
Other Financing Activities, net		 0.05 - - -0.05 - 0.00 - -0.03 -0.03 -0.00 -0.04
Cash Income Taxes Paid		 -0.00 0.00 0.02 -0.00 -0.00 0.02 - - -0.05 0.00 0.01

Annual Balance Sheets for IRIDEX

This table presents IRIDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026 1/3/2026
Total Assets		 42 48 42 42 35 49 42 34 29 29 29
Total Current Assets		 31 46 39 40 31 42 36 27 24 25 25
Cash & Equivalents		 10.00 24 22 21 13 24 14 7.03 2.39 6.03 6.03
Accounts Receivable		 9.28 10 7.86 9.08 9.32 9.72 6.23 6.73 5.95 7.61 7.61
Inventories, net		 11 12 9.38 8.79 8.17 7.61 11 9.91 11 7.88 7.88
Prepaid Expenses		 0.39 0.45 0.50 0.55 0.40 1.07 1.47 0.86 1.96 1.80 1.80
Other Current Assets		 - - - - - - 3.54 2.93 2.44 1.93 1.93
Plant, Property, & Equipment, net		 1.10 1.53 1.40 1.22 0.73 0.43 0.46 0.35 0.12 0.06 0.06
Total Noncurrent Assets		 9.95 0.75 0.79 0.83 3.53 6.01 6.06 6.64 5.46 3.84 3.84
Goodwill		 0.53 0.53 0.53 0.53 0.53 0.97 0.97 0.97 0.97 0.97 0.97
Intangible Assets		 0.27 0.13 0.12 0.10 0.08 2.21 1.98 1.64 1.31 0.98 0.98
Other Noncurrent Operating Assets		 0.16 0.08 0.14 0.20 2.92 2.84 3.12 4.03 3.19 1.89 1.89
Total Liabilities & Shareholders' Equity		 42 48 42 42 35 49 42 34 29 29 29
Total Liabilities		 8.14 8.98 11 12 12 25 25 25 27 24 24
Total Current Liabilities		 7.43 8.17 10 11 9.78 13 12 13 17 13 13
Accounts Payable		 2.22 1.99 1.72 2.52 2.59 3.40 3.86 4.50 6.99 5.39 5.39
Accrued Expenses		 2.33 2.45 3.69 3.39 1.92 1.68 1.72 2.00 0.48 0.61 0.61
Current Deferred Revenue		 1.31 1.38 2.52 1.64 1.45 2.36 2.41 2.40 2.18 2.16 2.16
Current Employee Benefit Liabilities		 1.57 2.35 2.46 2.96 2.40 3.19 2.45 1.62 1.67 2.34 2.34
Other Current Liabilities		 - - - - 1.41 2.03 2.02 2.46 3.52 2.72 2.72
Total Noncurrent Liabilities		 0.70 0.82 0.73 1.21 2.33 13 13 12 10 11 11
Long-Term Debt		 - - - - 0.00 - - 0.00 1.00 3.74 3.74
Noncurrent Deferred Revenue		 - - - 0.59 0.36 11 12 10 8.35 6.80 6.80
Other Noncurrent Operating Liabilities		 0.70 0.82 0.73 0.62 1.97 1.81 0.86 1.92 1.13 0.49 0.49
Commitments & Contingencies		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 34 39 31 30 23 23 17 9.52 2.10 4.92 4.92
Total Preferred & Common Equity		 34 39 31 30 23 23 17 9.52 2.10 4.92 4.92
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.00 6.00
Total Common Equity		 34 39 31 30 23 23 17 9.52 2.10 -1.08 -1.08
Common Stock		 38 55 60 72 73 85 87 89 90 91 91
Retained Earnings		 -4.41 -16 -29 -42 -51 -62 -70 -79 -88 -92 -92
Accumulated Other Comprehensive Income / (Loss)		 - - - 0.07 0.08 0.05 -0.02 -0.05 0.05 -0.01 -0.01

Quarterly Balance Sheets for IRIDEX

This table presents IRIDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026 7/4/2026
Total Assets		 35 34 31 30 34 32 28 28 27
Total Current Assets		 27 28 25 24 29 27 24 25 24
Cash & Equivalents		 7.98 5.42 4.11 3.86 7.24 6.78 5.57 4.60 4.68
Accounts Receivable		 6.11 6.53 6.27 5.95 6.68 7.14 7.13 6.84 5.67
Inventories, net		 10 11 11 11 10 8.44 7.30 9.33 9.75
Prepaid Expenses		 1.13 2.01 1.73 1.76 2.36 1.63 1.66 2.25 2.44
Other Current Assets		 2.01 2.62 1.77 1.83 2.71 2.89 2.40 1.57 1.42
Plant, Property, & Equipment, net		 0.52 0.27 0.21 0.16 0.08 0.04 0.02 0.14 0.18
Total Noncurrent Assets		 7.08 6.25 6.03 5.66 5.03 4.68 4.26 3.55 3.12
Goodwill		 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97
Intangible Assets		 1.73 1.56 1.48 1.39 1.22 1.14 1.06 0.90 0.83
Other Noncurrent Operating Assets		 4.39 3.73 3.59 3.30 2.84 2.57 2.24 1.68 1.33
Total Liabilities & Shareholders' Equity		 35 34 31 30 34 32 28 28 27
Total Liabilities		 23 28 27 28 27 26 24 24 24
Total Current Liabilities		 10 16 16 16 15 14 12 13 13
Accounts Payable		 2.61 7.68 7.77 6.20 6.05 5.31 4.41 5.75 6.65
Accrued Expenses		 1.42 1.11 0.87 1.01 0.97 0.58 0.59 0.69 0.76
Current Deferred Revenue		 2.24 2.45 2.29 2.34 2.09 2.27 2.21 2.04 2.15
Current Employee Benefit Liabilities		 2.20 2.26 2.14 1.84 2.02 1.86 1.93 1.72 1.63
Other Current Liabilities		 1.88 2.57 3.08 3.15 3.83 3.68 3.25 2.63 1.98
Total Noncurrent Liabilities		 13 12 11 12 12 12 11 11 10
Long-Term Debt		 - - - 1.44 3.64 3.68 3.71 3.77 3.80
Noncurrent Deferred Revenue		 10 9.71 9.26 8.76 7.97 7.59 7.21 6.42 6.08
Other Noncurrent Operating Liabilities		 2.07 1.83 1.60 1.48 0.83 0.56 0.37 0.53 0.57
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 12 6.49 4.25 2.62 0.85 6.06 4.68 4.73 3.64
Total Preferred & Common Equity		 12 6.49 4.25 2.62 0.85 6.06 4.68 4.73 3.64
Preferred Stock		 0.00 0.00 0.00 0.00 - 6.00 6.00 6.00 6.00
Total Common Equity		 12 6.49 4.25 2.62 0.85 0.06 -1.32 -1.27 -2.36
Common Stock		 88 89 89 90 91 91 91 92 92
Retained Earnings		 -76 -83 -85 -87 -90 -91 -92 -93 -94
Accumulated Other Comprehensive Income / (Loss)		 -0.02 -0.02 0.00 0.00 0.03 -0.01 -0.01 -0.01 -0.01

Annual Metrics And Ratios for IRIDEX

This table displays calculated financial ratios and metrics derived from IRIDEX's official financial filings.

Metric 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026 1/3/2026
DEI Shares Outstanding		 9,945,820.00 10,148,110.00 11,579,817.00 13,594,140.00 13,781,752.00 15,865,734.00 15,989,622.00 16,247,813.00 16,636,380.00 17,189,981.00 17,189,981.00
DEI Adjusted Shares Outstanding		 9,945,820.00 10,148,110.00 11,579,817.00 13,594,140.00 13,781,752.00 15,865,734.00 15,989,622.00 16,247,813.00 16,636,380.00 17,189,981.00 17,189,981.00
DEI Earnings Per Adjusted Shares Outstanding		 0.05 -1.15 -1.11 -0.94 -0.64 -0.33 -0.47 -0.59 -0.54 -0.26 -0.26
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -2.47% 10.54% -9.89% 2.42% 1.99% 0.00% 5.69% -8.96% -6.17% 8.23% 0.00%
EBITDA Growth		 -53.60% -346.99% -504.43% 1.40% 32.51% 0.00% -75.38% -22.14% 4.81% 63.24% 0.00%
EBIT Growth		 -78.15% -1,012.71% -389.27% 1.69% 31.39% 0.00% -44.30% -26.70% 6.73% 50.46% 0.00%
NOPAT Growth		 -97.59% -482.74% -402.46% 0.16% 30.26% 0.00% -0.12% -32.68% 17.04% 69.03% 0.00%
Net Income Growth		 -95.28% -2,571.10% -9.85% 0.42% 31.22% 0.00% -44.44% -26.81% 6.90% 50.20% 0.00%
EPS Growth		 -94.85% -2,400.00% 3.48% 5.41% 39.05% 0.00% -38.24% -25.53% 8.47% 51.85% 0.00%
Operating Cash Flow Growth		 -114.77% 75.72% -2,375.69% -181.21% 21.07% 0.00% -215.85% 29.14% -8.01% 70.97% 0.00%
Free Cash Flow Firm Growth		 -124.33% 332.35% -137.38% -269.68% 15.55% 0.00% 0.00% 32.35% 6.67% 65.68% 0.00%
Invested Capital Growth		 15.95% -34.95% -42.81% -0.54% 14.66% 0.00% 698.37% -24.81% -1.61% 7.39% 0.00%
Revenue Q/Q Growth		 0.81% 0.91% -5.21% 2.96% 0.68% 0.00% -0.10% -5.01% 0.49% 4.00% 0.00%
EBITDA Q/Q Growth		 75.22% -223.87% -53.13% 17.09% 13.49% 0.00% 25.27% -20.62% 20.76% 17.53% 0.00%
EBIT Q/Q Growth		 865.79% -118.78% -48.12% 16.22% 12.90% 0.00% 14.74% -22.89% 18.90% 13.37% 0.00%
NOPAT Q/Q Growth		 -14.41% -156.50% -47.36% 15.21% 12.59% 0.00% 11.57% -20.05% 23.71% 15.90% 0.00%
Net Income Q/Q Growth		 -94.61% -2,446.30% 30.55% 15.21% 12.81% 0.00% 14.65% -23.36% 19.26% 12.78% 0.00%
EPS Q/Q Growth		 -93.98% -3,733.33% 35.84% 18.60% 12.33% 0.00% 14.55% -22.92% 19.40% 13.33% 0.00%
Operating Cash Flow Q/Q Growth		 -159.30% -227.27% -19.91% -12.58% 19.05% 0.00% 1.53% 8.31% -3.69% 46.35% 0.00%
Free Cash Flow Firm Q/Q Growth		 70.56% 311.36% -137.28% -25.19% 19.00% -100.00% -8.37% 19.68% -14.16% 42.29% 0.00%
Invested Capital Q/Q Growth		 4.80% -38.29% -28.63% -1.32% -8.95% -124.80% 49.12% -39.06% 60.95% -6.54% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.78% 45.15% 37.27% 41.01% 41.29% 42.36% 44.53% 42.04% 40.07% 36.50% 36.50%
EBITDA Margin		 1.95% -4.35% -29.18% -28.09% -18.59% -6.45% -10.70% -14.36% -14.57% -4.95% -4.95%
Operating Margin		 0.69% -5.56% -30.99% -30.21% -20.66% -13.98% -13.24% -19.29% -17.06% -4.88% -4.88%
EBIT Margin		 0.70% -5.75% -31.24% -29.99% -20.17% -9.62% -13.13% -18.28% -18.17% -8.32% -8.32%
Profit (Net Income) Margin		 1.14% -25.38% -30.94% -30.08% -20.28% -9.69% -13.25% -18.45% -18.31% -8.42% -8.42%
Tax Burden Percent		 162.89% 441.00% 99.02% 100.29% 100.55% 100.77% 100.87% 100.95% 100.77% 101.30% 101.30%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 -62.89% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 2.13% -9.18% -74.47% -102.46% -66.76% 0.00% -383.12% -241.67% -235.47% -70.90% -68.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.08% 49.60% -57.55% -84.72% -51.80% 0.00% -371.11% -217.19% -142.74% 200.71% 46.56%
Return on Net Nonoperating Assets (RNNOA)		 -0.72% -22.97% 37.54% 60.10% 33.29% 0.00% 345.88% 170.13% 82.10% -55.53% -21.69%
Return on Equity (ROE)		 1.41% -32.16% -36.93% -42.37% -33.47% -22.43% -37.24% -71.54% -153.37% -126.43% -90.15%
Cash Return on Invested Capital (CROIC)		 -12.65% 33.16% -20.01% -101.92% -80.42% 0.00% -276.26% -213.35% -233.85% -78.03% 0.00%
Operating Return on Assets (OROA)		 0.70% -5.90% -28.95% -30.67% -22.92% -10.65% -16.45% -24.71% -27.82% -15.03% -15.03%
Return on Assets (ROA)		 1.13% -26.04% -28.66% -30.76% -23.05% -10.73% -16.59% -24.95% -28.03% -15.22% -15.22%
Return on Common Equity (ROCE)		 1.41% -32.16% -36.93% -42.37% -33.47% -22.43% -37.24% -71.54% -153.37% -18.35% 19.74%
Return on Equity Simple (ROE_SIMPLE)		 1.41% -29.91% -42.16% -42.77% -38.82% -22.43% -43.80% -100.50% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.47 -1.80 -9.02 -9.01 -6.28 -5.27 -5.28 -7.00 -5.81 -1.80 -1.80
NOPAT Margin		 1.12% -3.89% -21.69% -21.14% -14.46% -9.78% -9.27% -13.51% -11.94% -3.42% -3.42%
Net Nonoperating Expense Percent (NNEP)		 0.04% -58.78% -16.92% -17.74% -14.96% 0.20% -12.01% -24.48% -92.73% -271.61% -115.02%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -73.57% -120.19% -20.79% -20.79%
Cost of Revenue to Revenue		 52.22% 54.85% 62.73% 58.99% 58.71% 57.64% 55.47% 57.96% 59.93% 63.50% 63.50%
SG&A Expenses to Revenue		 13.29% 16.55% 21.11% 22.42% 19.29% 16.44% 13.26% 16.87% 20.09% 14.68% 14.68%
R&D to Revenue		 12.49% 11.62% 12.52% 9.40% 8.47% 12.74% 12.59% 13.17% 11.20% 6.96% 6.96%
Operating Expenses to Revenue		 47.09% 50.70% 68.26% 71.22% 61.94% 56.33% 57.77% 61.34% 57.13% 41.38% 41.38%
Earnings before Interest and Taxes (EBIT)		 0.29 -2.66 -13 -13 -8.77 -5.19 -7.48 -9.48 -8.84 -4.38 -4.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.81 -2.01 -12 -12 -8.08 -3.48 -6.10 -7.45 -7.09 -2.61 -2.61
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.74 3.64 2.89 2.02 1.43 4.16 1.87 4.79 13.25 0.00 0.00
Price to Tangible Book Value (P/TBV)		 2.81 3.71 2.95 2.06 1.47 4.82 2.25 6.60 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.21 3.09 2.12 1.42 0.75 1.80 0.56 0.88 0.57 0.38 0.38
Price to Earnings (P/E)		 194.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.48 7.72 7.55 4.48 1.96 0.00 5.51 15.52 11.49 9.06 9.06
Enterprise Value to Revenue (EV/Rev)		 1.97 2.58 1.60 0.92 0.45 1.36 0.32 0.74 0.58 0.45 0.45
Enterprise Value to EBITDA (EV/EBITDA)		 101.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 283.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 175.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 8.89 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 18.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.31 0.76 0.76
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.48 0.76 0.76
Financial Leverage		 -0.35 -0.46 -0.65 -0.71 -0.64 -1.02 -0.93 -0.78 -0.58 -0.28 -0.47
Leverage Ratio		 1.24 1.24 1.29 1.38 1.45 2.09 2.24 2.87 5.47 8.30 5.92
Compound Leverage Factor		 1.24 1.24 1.29 1.38 1.45 2.09 2.24 2.87 5.47 8.30 5.92
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 56.63% 43.14% 43.14%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 35.86% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.77% 43.14% 43.14%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 69.31% 69.31%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 43.37% -12.45% -12.45%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.39 -1.43 -1.43
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 0.88 0.88
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.14 -1.43 -1.43
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.47 -2.08 -2.08
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.06 1.27 1.27
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.17 -2.08 -2.08
Altman Z-Score		 8.36 10.78 4.59 2.54 0.70 1.99 -0.11 -1.01 -2.66 -2.13 -2.13
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 85.48% 121.90%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.14 5.62 3.80 3.77 3.12 3.34 2.87 2.12 1.42 1.91 1.91
Quick Ratio		 2.59 4.13 2.85 2.88 2.25 2.65 1.62 1.06 0.50 1.03 1.03
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.79 6.48 -2.42 -8.96 -7.57 0.00 -9.14 -6.18 -5.77 -1.98 0.00
Operating Cash Flow to CapEx		 -67.77% -13.56% -620.00% -2,278.41% -6,182.03% 3,857.75% -3,328.32% -6,188.07% -56,038.46% -1,479.02% -1,479.02%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.00 1.03 0.93 1.02 1.14 1.11 1.25 1.35 1.53 1.81 1.81
Accounts Receivable Turnover		 4.74 4.78 4.65 5.03 4.72 5.55 7.15 8.01 7.68 7.77 6.92
Inventory Turnover		 2.16 2.23 2.48 2.77 3.01 4.08 3.47 2.93 2.81 3.58 4.25
Fixed Asset Turnover		 45.41 34.99 28.32 32.48 44.56 125.94 128.03 127.60 208.88 608.96 908.19
Accounts Payable Turnover		 10.95 12.01 14.03 11.85 9.99 9.14 8.71 7.19 5.08 5.41 6.21
Days Sales Outstanding (DSO)		 77.00 76.34 78.49 72.60 77.31 65.79 51.08 45.59 47.54 46.99 52.75
Days Inventory Outstanding (DIO)		 169.28 163.98 147.06 132.00 121.40 89.44 105.22 124.54 129.67 102.00 85.96
Days Payable Outstanding (DPO)		 33.32 30.40 26.01 30.79 36.55 39.93 41.91 50.73 71.86 67.49 58.76
Cash Conversion Cycle (CCC)		 212.97 209.92 199.54 173.80 162.17 115.30 114.40 119.39 105.35 81.50 79.95
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 24 15 8.82 8.77 10 -0.55 3.31 2.49 2.45 2.63 2.63
Invested Capital Turnover		 1.89 2.36 3.43 4.85 4.62 -97.47 41.34 17.90 19.72 20.75 20.04
Increase / (Decrease) in Invested Capital		 3.26 -8.28 -6.60 -0.05 1.29 0.00 3.86 -0.82 -0.04 0.18 0.00
Enterprise Value (EV)		 82 119 67 39 20 73 18 39 28 24 24
Market Capitalization		 92 143 88 60 32 97 32 46 28 20 20
Book Value per Share		 $3.39 $3.86 $2.64 $2.20 $1.65 $1.47 $1.08 $0.59 $0.13 ($0.06) ($0.06)
Tangible Book Value per Share		 $3.31 $3.79 $2.58 $2.16 $1.60 $1.27 $0.89 $0.43 ($0.01) ($0.18) ($0.18)
Total Capital		 34 39 31 30 23 23 17 9.52 4.84 8.66 8.66
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.74 3.74 3.74
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 3.74 3.74
Net Debt		 -10.00 -24 -22 -21 -13 -24 -14 -7.03 0.35 -2.29 -2.29
Capital Expenditures (CapEx)		 0.88 1.06 0.58 0.44 0.13 0.21 0.29 0.11 0.01 0.14 0.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 13 14 7.35 7.92 8.12 5.76 9.39 7.44 6.35 6.02 6.02
Debt-free Net Working Capital (DFNWC)		 23 38 29 29 21 30 23 14 8.74 12 12
Net Working Capital (NWC)		 23 38 29 29 21 30 23 14 7.00 12 12
Net Nonoperating Expense (NNE)		 -0.00 9.92 3.85 3.81 2.53 -0.05 2.27 2.57 3.10 2.64 2.64
Net Nonoperating Obligations (NNO)		 -10.00 -24 -22 -21 -13 -24 -14 -7.03 0.35 -2.29 -2.29
Total Depreciation and Amortization (D&A)		 0.52 0.65 0.86 0.81 0.69 1.71 1.38 2.03 1.75 1.77 1.77
Debt-free, Cash-free Net Working Capital to Revenue		 31.95% 30.22% 17.68% 18.60% 18.69% 10.68% 16.48% 14.35% 13.05% 11.42% 11.42%
Debt-free Net Working Capital to Revenue		 55.89% 81.67% 69.87% 68.35% 47.81% 54.93% 40.92% 27.91% 17.95% 22.86% 22.86%
Net Working Capital to Revenue		 55.89% 81.67% 69.87% 68.35% 47.81% 54.93% 40.92% 27.91% 14.39% 22.86% 22.86%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.05 ($1.15) ($1.11) ($1.05) ($0.64) $0.00 ($0.47) ($0.59) ($0.54) ($0.26) ($0.26)
Adjusted Weighted Average Basic Shares Outstanding		 9.96M 10.17M 11.56M 12.20M 13.71M 0.00 15.94M 16.13M 16.44M 16.93M 16.93M
Adjusted Diluted Earnings per Share		 $0.05 ($1.15) ($1.11) ($1.05) ($0.64) $0.00 ($0.47) ($0.59) ($0.54) ($0.26) ($0.26)
Adjusted Weighted Average Diluted Shares Outstanding		 10.13M 10.17M 11.56M 12.20M 13.71M 0.00 15.94M 16.13M 16.44M 16.93M 16.93M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.05M 11.52M 11.63M 13.63M 13.79M 0.00 16.01M 16.25M 16.79M 17.31M 17.31M
Normalized Net Operating Profit after Tax (NOPAT)		 0.20 -1.71 -9.12 -9.01 -6.28 -5.27 -5.28 -7.00 -5.81 -1.80 -1.80
Normalized NOPAT Margin		 0.48% -3.71% -21.93% -21.14% -14.46% -9.78% -9.27% -13.51% -11.94% -3.42% -3.42%
Pre Tax Income Margin		 0.70% -5.75% -31.24% -29.99% -20.17% -9.62% -13.13% -18.28% -18.17% -8.32% -8.32%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 329.75% -0.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for IRIDEX

This table displays calculated financial ratios and metrics derived from IRIDEX's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
DEI Shares Outstanding		 16,247,813.00 16,252,813.00 16,252,948.00 16,509,412.00 16,636,380.00 16,789,027.00 16,789,027.00 16,992,253.00 17,189,981.00 17,307,401.00 17,406,518.00
DEI Adjusted Shares Outstanding		 16,247,813.00 16,252,813.00 16,252,948.00 16,509,412.00 16,636,380.00 16,789,027.00 16,789,027.00 16,992,253.00 17,189,981.00 17,307,401.00 17,406,518.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.18 -0.21 -0.16 -0.12 -0.05 -0.10 -0.06 -0.09 -0.01 -0.03 -0.07
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -18.01% -14.19% -1.74% -9.88% 1.91% 1.15% 7.44% 7.80% 15.97% -0.82% -7.41%
EBITDA Growth		 -149.59% -78.66% -2.23% -8.56% 87.48% 61.73% 75.38% 22.32% 208.27% 94.47% -42.55%
EBIT Growth		 -155.73% -64.87% 3.48% -9.74% 71.03% 51.14% 63.42% 18.11% 80.48% 72.16% -22.92%
NOPAT Growth		 -118.51% -40.49% 8.85% -10.78% 83.74% 93.77% 64.37% 24.55% 97.01% -58.05% -9.47%
Net Income Growth		 -157.84% -65.74% 3.15% -10.21% 71.82% 51.33% 62.90% 18.62% 77.94% 68.92% -27.36%
EPS Growth		 -157.14% -61.54% 5.88% -9.09% 72.22% 52.38% 62.50% 25.00% 80.00% 70.00% -16.67%
Operating Cash Flow Growth		 38.43% 42.03% -16.21% -72.45% -26.46% 30.28% 70.06% 62.32% 147.58% -16.19% 143.83%
Free Cash Flow Firm Growth		 72.45% 125.33% 139.33% 141.14% 76.74% -259.14% -311.18% -281.94% 38.37% 62.31% 85.10%
Invested Capital Growth		 -24.81% -77.90% -96.28% -62.75% -1.61% 204.21% 2,089.63% 84.94% 7.39% 19.99% -6.83%
Revenue Q/Q Growth		 -3.05% -5.59% 7.40% -8.31% 9.63% -6.30% 14.08% -8.01% 17.94% 0.00% 6.50%
EBITDA Q/Q Growth		 -52.70% -42.33% 24.21% 34.09% 82.38% -334.96% 51.25% -107.98% 124.55% 0.00% -1,156.25%
EBIT Q/Q Growth		 -66.09% -18.14% 22.36% 27.97% 56.16% -99.29% 41.88% -61.25% 89.55% 0.00% -156.65%
NOPAT Q/Q Growth		 -82.52% -6.88% 19.89% 29.11% 73.21% 59.08% -358.54% -50.11% 98.94% 0.00% -217.59%
Net Income Q/Q Growth		 -68.76% -17.03% 22.66% 27.85% 56.85% -102.16% 41.04% -58.25% 88.30% 0.00% -141.60%
EPS Q/Q Growth		 -63.64% -16.67% 23.81% 25.00% 58.33% -100.00% 40.00% -50.00% 88.89% 0.00% -133.33%
Operating Cash Flow Q/Q Growth		 45.06% -68.34% 19.54% -131.75% 59.71% 7.19% 65.45% -191.69% 150.86% 0.00% 113.03%
Free Cash Flow Firm Q/Q Growth		 56.14% 209.45% 12.69% -23.94% -124.80% -648.79% -49.54% 34.47% 91.60% 0.00% 40.89%
Invested Capital Q/Q Growth		 -39.06% -57.03% -87.37% 1,026.67% 60.95% 32.84% -9.10% -4.84% -6.54% 0.00% -29.42%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 39.21% 37.90% 40.65% 37.33% 44.00% 42.49% 34.50% 32.15% 37.20% 40.18% 34.19%
EBITDA Margin		 -17.05% -25.70% -18.14% -13.04% -2.10% -9.73% -4.16% -9.40% 1.96% -0.54% -6.40%
Operating Margin		 -24.73% -28.00% -20.89% -16.15% -3.95% -1.72% -6.93% -11.30% -0.10% -2.75% -8.19%
EBIT Margin		 -23.28% -29.13% -21.06% -16.54% -6.62% -14.07% -7.17% -12.57% -1.11% -3.95% -9.52%
Profit (Net Income) Margin		 -23.76% -29.45% -21.21% -16.69% -6.57% -14.17% -7.32% -12.60% -1.25% -4.44% -10.07%
Tax Burden Percent		 102.07% 101.11% 100.71% 100.89% 99.29% 100.72% 102.16% 100.25% 112.20% 112.45% 105.85%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -309.80% -331.41% -386.08% -195.37% -54.47% -27.25% -156.06% -184.91% -1.48% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -302.13% -317.33% -374.13% -181.63% -40.01% 6.96% -146.74% -145.50% 16.39% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 236.66% 233.58% 294.55% 112.32% 23.01% -4.70% 102.73% 59.16% -4.53% 0.00% 0.00%
Return on Equity (ROE)		 -73.13% -97.83% -91.53% -83.04% -31.46% -31.95% -53.33% -125.75% -6.01% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 -213.35% -132.17% -212.33% -180.42% -233.85% -269.97% -341.78% -158.37% -78.03% -18.17% 7.08%
Operating Return on Assets (OROA)		 -31.47% -38.74% -30.70% -24.62% -10.13% -20.10% -11.35% -21.76% -2.01% 0.00% 0.00%
Return on Assets (ROA)		 -32.12% -39.17% -30.92% -24.83% -10.06% -20.25% -11.60% -21.81% -2.26% 0.00% 0.00%
Return on Common Equity (ROCE)		 -73.13% -97.83% -91.53% -83.04% -31.46% -17.58% -22.28% -22.45% -0.87% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -168.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.16 -2.31 -1.85 -1.31 -0.35 -0.14 -0.66 -0.99 -0.01 -0.23 -0.72
NOPAT Margin		 -17.31% -19.60% -14.62% -11.30% -2.76% -1.21% -4.85% -7.91% -0.07% -1.92% -5.73%
Net Nonoperating Expense Percent (NNEP)		 -7.67% -14.08% -11.95% -13.74% -14.46% -34.21% -9.32% -39.41% -17.87% -13.42% -27.37%
Return On Investment Capital (ROIC_SIMPLE)		 -22.65% -35.53% -43.49% -24.33% -7.25% -3.19% -6.76% -11.78% -0.12% -2.67% -9.69%
Cost of Revenue to Revenue		 60.79% 62.10% 59.35% 62.67% 56.00% 57.51% 65.50% 67.85% 62.80% 59.82% 65.81%
SG&A Expenses to Revenue		 19.30% 20.98% 22.05% 19.41% 17.92% 16.23% 16.33% 14.38% 12.17% 13.76% 14.66%
R&D to Revenue		 13.60% 13.06% 11.88% 11.22% 8.77% 7.36% 6.42% 7.79% 6.45% 7.67% 7.45%
Operating Expenses to Revenue		 63.94% 65.90% 61.54% 53.48% 47.94% 44.22% 41.43% 43.45% 37.30% 42.93% 42.38%
Earnings before Interest and Taxes (EBIT)		 -2.90 -3.43 -2.66 -1.92 -0.84 -1.67 -0.97 -1.57 -0.16 -0.47 -1.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.12 -3.02 -2.29 -1.51 -0.27 -1.16 -0.56 -1.17 0.29 -0.06 -0.80
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.79 7.47 8.27 11.27 13.25 19.69 250.41 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 6.60 12.22 19.44 110.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.88 0.97 0.71 0.61 0.57 0.34 0.30 0.39 0.38 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 15.52 40.24 229.60 18.70 11.49 5.90 5.98 8.42 9.06 5.67 9.00
Enterprise Value to Revenue (EV/Rev)		 0.74 0.86 0.62 0.59 0.58 0.39 0.36 0.47 0.45 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 122.69
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 1.05 1.31 0.53 0.61 0.79 0.76 0.80 1.04
Long-Term Debt to Equity		 0.00 0.00 0.00 0.55 0.48 0.53 0.61 0.79 0.76 0.80 1.04
Financial Leverage		 -0.78 -0.74 -0.79 -0.62 -0.58 -0.68 -0.70 -0.41 -0.28 -0.38 -0.41
Leverage Ratio		 2.87 3.36 3.85 4.43 5.47 5.12 6.10 8.01 8.30 5.40 6.07
Compound Leverage Factor		 2.87 3.36 3.85 4.43 5.47 5.12 6.10 8.01 8.30 5.40 6.07
Debt to Total Capital		 0.00% 0.00% 0.00% 51.25% 56.63% 34.72% 37.75% 44.18% 43.14% 44.31% 51.05%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 24.42% 35.86% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 26.84% 20.77% 34.72% 37.75% 44.18% 43.14% 44.31% 51.05%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 61.64% 71.55% 69.31% 70.61% 80.71%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 57.16% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 48.75% 43.37% 8.12% 0.61% -15.73% -12.45% -14.92% -31.76%
Debt to EBITDA		 0.00 0.00 0.00 -0.31 -0.39 -0.70 -1.05 -1.17 -1.43 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.12 -0.05 0.69 0.89 0.59 0.88 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 -0.16 -0.14 -0.70 -1.05 -1.17 -1.43 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 -0.36 -0.47 -1.00 -1.49 -1.73 -2.08 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.14 -0.06 0.99 1.26 0.87 1.27 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -0.19 -0.17 -1.00 -1.49 -1.73 -2.08 0.00 0.00
Altman Z-Score		 -0.38 -0.80 -1.39 -1.67 -1.75 -1.54 -1.70 -1.96 -1.66 -3.73 -4.01
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 44.98% 58.22% 82.15% 85.48% 103.59% 123.74%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.12 1.72 1.55 1.54 1.42 1.95 1.96 1.94 1.91 1.92 1.82
Quick Ratio		 1.06 0.74 0.64 0.62 0.50 0.93 1.02 1.03 1.03 0.89 0.79
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.34 1.46 1.65 1.25 -0.31 -2.33 -3.48 -2.28 -0.19 -0.88 -0.52
Operating Cash Flow to CapEx		 0.00% -54,933.33% 0.00% -307,300.00% -13,755.56% -10,445.45% -3,053.85% -8,907.69% 555.66% -1,321.78% 348.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.35 1.33 1.46 1.49 1.53 1.43 1.58 1.73 1.81 0.00 0.00
Accounts Receivable Turnover		 8.01 5.78 7.84 8.03 7.68 7.39 7.42 7.74 7.77 0.00 0.00
Inventory Turnover		 2.93 2.66 2.66 2.81 2.81 2.72 3.08 3.43 3.58 0.00 0.00
Fixed Asset Turnover		 127.60 139.84 164.03 142.23 208.88 287.08 399.55 562.74 608.96 0.00 0.00
Accounts Payable Turnover		 7.19 5.22 4.97 6.73 5.08 4.18 4.60 5.90 5.41 0.00 0.00
Days Sales Outstanding (DSO)		 45.59 63.18 46.58 45.46 47.54 49.38 49.18 47.15 46.99 0.00 0.00
Days Inventory Outstanding (DIO)		 124.54 137.16 137.20 129.71 129.67 134.44 118.60 106.33 102.00 0.00 0.00
Days Payable Outstanding (DPO)		 50.73 69.99 73.44 54.27 71.86 87.29 79.32 61.84 67.49 0.00 0.00
Cash Conversion Cycle (CCC)		 119.39 130.36 110.35 120.90 105.35 96.53 88.46 91.64 81.50 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2.49 1.07 0.14 1.52 2.45 3.25 2.96 2.81 2.63 3.90 2.75
Invested Capital Turnover		 17.90 16.91 26.41 17.28 19.72 22.59 32.19 23.37 20.75 0.00 0.00
Increase / (Decrease) in Invested Capital		 -0.82 -3.77 -3.49 -2.56 -0.04 2.18 2.82 1.29 0.18 0.65 -0.20
Enterprise Value (EV)		 39 43 31 28 28 19 18 24 24 22 25
Market Capitalization		 46 48 35 30 28 17 15 20 20 17 20
Book Value per Share		 $0.59 $0.40 $0.26 $0.16 $0.13 $0.05 $0.00 ($0.08) ($0.06) ($0.07) ($0.14)
Tangible Book Value per Share		 $0.43 $0.24 $0.11 $0.02 ($0.01) ($0.08) ($0.12) ($0.20) ($0.18) ($0.18) ($0.24)
Total Capital		 9.52 6.49 4.25 5.38 4.84 10 9.73 8.39 8.66 8.50 7.43
Total Debt		 0.00 0.00 0.00 2.76 2.74 3.64 3.68 3.71 3.74 3.77 3.80
Total Long-Term Debt		 0.00 0.00 0.00 1.44 1.00 3.64 3.68 3.71 3.74 3.77 3.80
Net Debt		 -7.03 -5.42 -4.11 -1.10 0.35 -3.60 -3.10 -1.87 -2.29 -0.83 -0.89
Capital Expenditures (CapEx)		 -0.03 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.11 0.10 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.44 6.09 4.75 5.94 6.35 6.94 6.38 6.10 6.02 7.16 6.11
Debt-free Net Working Capital (DFNWC)		 14 12 8.86 9.80 8.74 14 13 12 12 12 11
Net Working Capital (NWC)		 14 12 8.86 8.49 7.00 14 13 12 12 12 11
Net Nonoperating Expense (NNE)		 0.80 1.16 0.83 0.62 0.48 1.54 0.34 0.59 0.17 0.30 0.55
Net Nonoperating Obligations (NNO)		 -7.03 -5.42 -4.11 -1.10 0.35 -3.60 -3.10 -1.87 -2.29 -0.83 -0.89
Total Depreciation and Amortization (D&A)		 0.78 0.40 0.37 0.41 0.57 0.52 0.41 0.40 0.45 0.40 0.39
Debt-free, Cash-free Net Working Capital to Revenue		 14.35% 12.20% 9.56% 12.26% 13.05% 14.22% 12.83% 12.05% 11.42% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 27.91% 23.06% 17.83% 20.23% 17.95% 29.06% 26.45% 23.05% 22.86% 0.00% 0.00%
Net Working Capital to Revenue		 27.91% 23.06% 17.83% 17.52% 14.39% 29.06% 26.45% 23.05% 22.86% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.18) ($0.21) ($0.16) ($0.12) ($0.05) ($0.10) ($0.06) ($0.09) ($0.01) ($0.03) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding		 16.13M 16.25M 16.29M 16.58M 16.44M 16.73M 16.79M 17.01M 16.93M 17.31M 17.42M
Adjusted Diluted Earnings per Share		 ($0.18) ($0.21) ($0.16) ($0.12) ($0.05) ($0.10) ($0.06) ($0.09) ($0.01) ($0.03) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding		 16.13M 16.25M 16.29M 16.58M 16.44M 16.73M 16.79M 17.01M 16.93M 17.31M 17.42M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.25M 16.25M 16.51M 16.64M 16.79M 16.79M 16.99M 17.19M 17.31M 17.41M 17.56M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.16 -2.31 -1.85 -1.31 -0.35 -0.14 -0.66 -0.99 -0.01 -0.23 -0.72
Normalized NOPAT Margin		 -17.31% -19.60% -14.62% -11.30% -2.76% -1.21% -4.85% -7.91% -0.07% -1.92% -5.73%
Pre Tax Income Margin		 -23.28% -29.13% -21.06% -16.54% -6.62% -14.07% -7.17% -12.57% -1.11% -3.95% -9.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

IRIDEX’s recent results show revenue growth from 2023 levels, but profitability remains inconsistent. Quarterly revenue increased from $12.5 million in Q4 2023 to $12.6 million in Q2 2026, with a peak of $14.7 million in Q4 2025. However, gross margin has fluctuated considerably, reaching 44.0% in Q4 2024 before falling to 34.2% in Q2 2026. The company has reported an operating loss in every quarter provided.

Losses have generally narrowed from the steep losses reported in early 2024. Net loss improved from $3.5 million in Q1 2024 to $184,000 in Q4 2025, but widened again to $1.3 million in Q2 2026. The latest quarter’s $1.0 million operating loss and $167,000 of net other expense indicate that IRIDEX has not yet achieved sustainable operating profitability.

Cash flow has also been volatile. IRIDEX generated $174,000 in net cash from operating activities in Q2 2026, following a $1.3 million outflow in Q1 2026 and a $589,000 inflow in Q4 2025. On a continuing-operations basis, however, Q2 operating cash flow remained negative at $225,000. The company’s cash balance was $4.7 million at the end of Q2 2026, compared with $7.2 million in Q1 2025.

The balance sheet provides some liquidity but remains pressured by accumulated losses and leverage. Current assets of $24.0 million exceeded current liabilities of $13.2 million, producing a current ratio of approximately 1.8. However, total liabilities were $23.6 million versus only $3.6 million of total equity, while common equity was negative $2.4 million. Long-term debt stood at $3.8 million, and total assets declined from $34.9 million in Q3 2023 to $27.3 million in Q2 2026.

  • Revenue has held above early-2024 levels: Q2 2026 revenue of $12.6 million was higher than the $11.6 million reported in Q3 2024 and broadly consistent with the company’s recent quarterly range.
  • Losses are substantially narrower than in early 2024: The Q2 2026 net loss of $1.3 million compares with losses of $3.5 million in Q1 2024 and $2.7 million in Q2 2024.
  • Operating cash flow improved sequentially: Net cash from operating activities turned positive at $174,000 in Q2 2026 after a $1.3 million outflow in Q1.
  • Liquidity remains adequate in the near term: Current assets of $24.0 million were approximately 1.8 times current liabilities of $13.2 million.
  • Capital spending is limited: Q2 2026 purchases of property and equipment were only $50,000, reducing near-term investment-related cash demands.
  • Gross margins remain volatile: The margin has ranged from roughly 32% to 44% across the reported quarters, making it difficult to establish a consistent profitability trend.
  • Share count has gradually increased: Weighted average basic shares rose from 16.1 million in Q4 2023 to 17.4 million in Q2 2026, which may dilute per-share results over time.
  • IRIDEX has not produced a quarterly operating profit: The company posted a $1.0 million operating loss in Q2 2026, following a $324,000 loss in Q1 2026 and a $15,000 loss in Q4 2025.
  • Recent gross-margin deterioration is a concern: Q2 2026 gross profit fell to $4.3 million from $5.5 million in Q4 2025, while gross margin dropped to 34.2% from 37.2%.
  • The capital structure remains fragile: Total liabilities of $23.6 million substantially exceeded common equity, which was negative $2.4 million, and retained earnings were negative $94.2 million.
09/20/26 03:01 AM ETAI Generated. May Contain Errors.

IRIDEX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IRIDEX's fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

IRIDEX's net income appears to be on a downward trend, with a most recent value of -$4.44 million in 2026, falling from $474 thousand in 2015. The previous period was -$4.44 million in 2025. See where experts think IRIDEX is headed by visiting IRIDEX's forecast page.

IRIDEX's total operating income in 2026 was -$2.57 million, based on the following breakdown:
  • Total Gross Profit: $19.23 million
  • Total Operating Expenses: $21.80 million

Over the last 10 years, IRIDEX's total revenue changed from $41.76 million in 2015 to $52.68 million in 2026, a change of 26.1%.

IRIDEX's total liabilities were at $24.23 million at the end of 2026, which was unchanged from 2025, and a 197.8% increase since 2015.

In the past 10 years, IRIDEX's cash and equivalents has ranged from $2.39 million in 2024 to $23.85 million in 2021, and is currently $6.03 million as of their latest financial filing in 2026.

Over the last 10 years, IRIDEX's book value per share changed from 3.39 in 2015 to -0.06 in 2026, a change of -101.9%.


Related Companies

Financial statements for NASDAQ:IRIX last updated on 9/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
“Elon’s nightmare” could fund your retirement
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
You’ve never seen anything like this before
For centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...
Porter & Company | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
NVDA CEO says it’s a "once-in-a-generation opportunity"
NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel